QUOTE AND NEWS
DailyFinance  Aug 25  Comment 
SAN FRANCISCO, CA -- (Marketwired) -- 08/25/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference: David Hung, M.D., president and chief executive officer, and Rick Bierly, chief financial officer,...
StreetInsider.com  Aug 8  Comment 
The following is a list of notable articles to help get you through the lunch hour: Medivation (MDVN) Rips on Strong Xtandi; Maxim Group Still Sees Significant Potential -> Read this! S&P Raises Springleaf Holdings (LEAF) to 'B'; Leverage to...
TheStreet.com  Aug 8  Comment 
NEW YORK (TheStreet) -- Medivation shares are up 9.3% to $82.27 on Friday after having its price target raised by analysts at Brean Capital and StifelĀ , who both reiterated their "buy" rating on the stock.Brean Capital analysts raised its price...
Benzinga  Aug 8  Comment 
Tekmira Pharmaceuticals (NASDAQ: TKMR) shares moved up 17.52% to $16.77. The volume of Tekmira Pharmaceuticals shares traded was 2887% higher than normal. Tekmira Pharma said a Food and Drug Administration action may enable the use of the...
SeekingAlpha  Aug 8  Comment 
Medivation (NASDAQ:MDVN) Q2 2014 Earnings Call August 07, 2014 4:30 pm ET Executives Anne Bowdidge - Senior Director of Investor Relations David T. Hung - Founder, Chief Executive Officer, President and Executive Director Rick...
DailyFinance  Aug 7  Comment 
2nd Quarter Collaboration Revenue Increased 111% Year-Over-Year; 2nd Quarter U.S. Net Sales of XTANDI Increased 74% Year-Over-Year; Conference Call Today at 4:30 p.m. Eastern TimeSAN FRANCISCO, CA -- (Marketwired) -- 08/07/14 -- Medivation, Inc....
SeekingAlpha  Aug 7  Comment 
The following audio is from a conference call that will begin on August 07, 2014 at 16:30 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story Ā»
SeekingAlpha  Jul 21  Comment 
By Stock Doctor: Investors in biotechnology stocks, including myself, are always trying to balance risk and reward when purchasing stocks in this highly volatile sector. Having a biomedical Ph.D., I spend endless hours poring over data looking for...
Benzinga  Jul 10  Comment 
Medivation, Inc. (NASDAQ: MDVN) today announced Dawn Svoronos (formerly Graham) has been appointed as its chief commercial officer, reporting to David Hung, M.D., founder, chief executive officer and president of Medivation. Ms. Svoronos currently...
SeekingAlpha  Jul 10  Comment 
By Stock Doctor: When scouring biotechnology stocks to invest in, I look for undervalued companies that are developing or have approved drugs to treat diseases with high unmet clinical need with the potential to reach blockbuster status (a drug...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki